Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3
Yahoo Finance UK · 5 hours ago
Open | 756.56 |
High | 757.50 |
Low | 736.19 |
Mkt. Cap | 81.11b |
P/E(TTM) | 18.37 |
Div & Yield | N/A & N/A |
Prev. Close | 762.00 |
52 Wk. Low | 736.19 |
52 Wk. High | 1,211.20 |
Related stocks
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Wikipedia
REGN (NasdaqGS) $743.14 -18.86 (-2.48%)
Tue, Nov 19, 2024, 3:45PM EST
(USD) | Q3 2024 | Y/Y |
---|---|---|
Revenue | 3.72B | 10.60% ▲ |
Net Income | 1.34B | 33.00% ▲ |
Diluted EPS | 12.46 | 29.80% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q4 2024 | $11.09 | - |
Q3 2024 | $11.71 | $12.46 |
Q2 2024 | $10.62 | $11.56 |
NIKKEI 225^N225 | 38,414.43+193.58 (+0.51%) |
HANG SENG^HSI | 19,663.67+87.06 (+0.44%) |
CRUDE OILCL=F | 69.59+0.43 (+0.62%) |